News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Phoqus Limited Gets IND for Chronocort in USA; Sees Drug Marketed from Q1 2009



8/30/2007 10:54:09 AM

LONDON (Thomson Financial) - Phoqus Group PLC said it has received Investigational New Drug status from US Food Drug and Administration for its lead product Chronocort and added it has begun a Phase II clinical trial for the drug in patients with cortisol deficiency and androgen excess.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES